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Abstract
Background. Accelerated atherosclerosis is the major
cause of mortality in patients on chronic haemodialysis
(HD). Increased oxidative stress might be the major fac-
tor leading to high cardiovascular mortality rate in HD
patients. The aim of our study was to clarify effects of
uraemia and dialysis on oxidative stress parameters and
explore the relation between oxidative stress markers and
carotid artery intima-media thickness (CIMT) as an indica-
tor of atherosclerosis.
Methods. Twenty chronic HD patients, 20 predialytic
uraemic patients and 20 healthy subjects were included
in the study. Serum thiobarbituric acid reactive sub-
stances (TBARS), protein carbonyl content (PCO) and
nitrite/nitrate levels were determined as oxidative stress
markers. Serum vitamin E, plasma sulfhydryl (P-SH), ery-
throcyte glutathione (GSH), superoxide dismutase (SOD),
catalase (CAT) and glutathione peroxidase (GPx) activi-
ties were measured as antioxidants. CIMT was assessed by
carotid artery ultrasonography.
Results. Both chronic HD and predialytic uraemic patients
had enhanced oxidative stress indicated by higher levels of
nitrite/nitrate, TBARS and PCO, and lower levels of P-SH,
SOD, CAT and GPx compared to controls. HD patients had
significantly higher CIMT and nitrite/nitrate while signifi-
cantly lower P-SH,vitamin E, SOD, CAT and GPx compared
to predialytic uraemic patients. There was a significant pos-
itive correlation between CIMT and TBARS (r = 0.38,
P = 0.003) and nitrite/nitrate levels (r = 0.41, P = 0.001),
while there was a significant negative correlation between
CIMT and SOD (r = −0.35, P = 0.01), CAT (r = −0.65,
P < 0.001) and P-SH levels (r = −0.50, P < 0.001). A
linear regression analysis showed that TBARS were still
significantly and positively correlated with CIMT (P =
0.001), while CAT and P-SH were significantly and neg-
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atively correlated with CIMT (P = 0.002 and P = 0.048,
respectively).
Conclusions. HD exacerbates oxidative stress and distur-
bances in antioxidant enzymes in uraemic patients. We pro-
pose that serum TBARS and nitrite/nitrate can be used as
positive determinants, while erythrocyte SOD, CAT and
P-SH may be used as negative determinants of atheroscle-
rosis assessed by CIMT in uraemic and HD patients.
Keywords: carotid artery intima media thickness; chronic
haemodialysis patients; oxidative stress
Introduction
Atherosclerosis is accepted as a common mechanism un-
derlying all cardiovascular diseases (CVDs) and atheroscle-
rotic CVD is a significant cause of morbidity and mor-
tality in patients with end-stage renal disease (ESRD)
[1–3]. Evidence showed that there is an increased incidence
and accelerated worsening of atherosclerosis in patients on
chronic haemodialysis (HD). A marked increase in coro-
nary artery disease (CAD) incidence and death rates has
been reported in HD patients when compared with an age-
matched general population or non-uraemic populations
with hyperlipidaemia and hypertension [2]. In patients on
maintenance HD, 40–50% of deaths are attributed to lethal
cardiac events, and thus the rate of cardiac mortality is
∼5–20 times higher than that in the normal population [4].
Even in predialytic uraemic patients who are not on main-
tenance HD, it has been shown that the intima-media thick-
ness (IMT) of the carotid and femoral arteries is increased
[5]. Damage of large arteries, characterized by increased
IMT and arteriosclerosis, is a contributing factor to mortal-
ity in patients with ESRD [6,7].
The reason for the rapid clinical progression of CAD
in patients with ESRD is not completely understood. It
has been suggested that uraemia itself may pose a specific
risk for this patient group and several studies have focused
C© The Author [2008]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved.
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on oxidative stress in uraemia. The association between
oxidative stress and atherosclerosis was recognized by
Glavind et al. [8] as early as 1952. Oxidative stress, which
results from an imbalance between reactive oxygen (ROS)
and nitrogen species (RNS) production and antioxidant de-
fence mechanisms, is now well recognized in chronic kid-
ney disease and HD patients. Increased oxidative stress
could be involved in accelerated atherosclerosis in these
patients [9–11]. A number of recent studies, both in rats
and uraemic patients, have raised the hypothesis that an
impaired NO (nitric oxide) synthetic pathway could have a
key role in mediating the complex renal haemodynamic and
non-haemodynamic disorders associated with progression
of RD [12,13].
Common carotid IMT (CIMT) as measured by ultra-
sonography represents a marker of structural atherosclero-
sis. Increased CIMT has been shown to be correlated with
CV risk [14] and severity of coronary atherosclerosis [15]
and is helpful in predicting CV events in population groups
[16,17]. Increased CIMT is considered as an early phase of
atherosclerosis and might be seen even in patients with mild
hypertension and normal serum cholesterol [18]. Assess-
ment of CIMT using high-resolution B-mode ultrasonogra-
phy is a reliable, reproducible and non-invasive method for
detecting and monitoring the progression of atherosclerosis
[19].
The aim of our study was to clarify the respective ef-
fects of uraemia and HD on oxidative stress parameters and
explore any relation between CIMT and oxidative stress
markers and antioxidants in ESRD patients. We determined
CIMT as an indicator of atherosclerosis; serum thiobarbi-
turic acid reactive substances (TBARS) as an indicator of
lipid peroxidation; plasma protein carbonyl content (PCO)
as a marker of oxidative protein damage and serum ni-
trite/nitrate levels as indicators of RNS production. We
measured erythrocyte glutathione level (GSH), superoxide
dismutase (SOD), catalase (CAT) and glutathione perox-
idase (GPx) activities, and plasma sulfhydryl (P-SH) and
serum vitamin E concentrations as antioxidant markers.
Subjects and methods
The investigation conforms to the principles outlined in
the Declaration of Helsinki. The study was approved by
the local ethics committee and all participants gave written
informed consent.
Twenty predialytic uraemic patients (uraemic group) and
20 HD patients (HD group) attending the Nephrology De-
partment of Akdeniz University Medical Faculty were in-
cluded in the study. Patients in the uraemic group had creati-
nine clearance between 15 and 60 ml/min/1.73 m2. Patients
in the HD group had creatinine clearance <10 ml/min/
1.73 m2 and had been on chronic HD treatment for
>6 months (the mean duration of HD treatment was 5.8 ±
0.8 years). HD patients were dialyzed three times a week
with synthetic or hemisynthetic membrane, each session
lasting 4 h with bicarbonate dialysate.
Twenty healthy individuals who proved to be in a good
state of health and free from any signs of chronic disease
after a careful clinical examination and laboratory check-up
were included in the study as the control group. All controls
were non-smokers and did not consume alcohol regularly.
The intake of analgesics, vitamins or anti-inflammatory
drugs was stopped 4 weeks before blood sampling in both
patient groups and controls.
Determination of the oxidative stress markers
Fasting blood samples were obtained from all subjects. In
the HD group, blood samples were collected before the first
weekly HD treatment.
Serum was obtained by centrifugation at 3000 g for
10 min. The serum TBARS level was determined by the
fluorometric method of Wasowicz et al. and the results were
expressed as nmol/ml [20]. Serum nitrite and nitrate levels
were measured by the methods of Kader et al. [21] and
Bories et al. [22], respectively. Serum vitamin E concentra-
tion was measured as described by Desai using a standard
curve of known concentrations of D-α-tocopherol acetate
[23].
Haemolysates were prepared from samples collected into
vacuum tubes containing 1.7 mg/ml K3 EDTA as antico-
agulant. After centrifugation at 3000 g for 15 min, plasma
and buffy coat were removed from the pellet. P-SH concen-
tration was determined by the method of Koster et al. [24].
PCO of oxidatively modified proteins was determined by
the method of Reznick et al. [25]. Absorbance of the sam-
ple was measured at 360 nm and the result was given as
µmol/l carbonyl by using εmax 22 000 M−1 cm−1. Ery-
throcytes were washed three times in an ice-cold isotonic
sodium chloride solution (1:10, v/v) and were resuspended
in a washing solution to give 50% suspension. Haemol-
ysis of washed cell suspension was achieved by mixing
1 volume with 9 volumes of distilled water. Haemolysate
obtained was divided into two aliquots. The first aliquot
was used to determine haemoglobin concentration using
the cyanomethaemoglobin method [26]. The second aliquot
was used for determination of reduced GSH and enzymatic
activities of SOD [27], CAT [28] and GPx [29]. Erythrocyte
GSH concentration was measured by the method of Fair-
banks and Klee and expressed as mg/gHb [26]. Erythrocyte
Cu, Zn–SOD activity was assayed using the spectrophoto-
metric indirect inhibition technique of Misra and Fridovich,
based on the ability of SOD to inhibit auto-oxidation of
adrenalin to adrenochrome at alkaline pH [27]. CAT ac-
tivity was measured using the Aebi method based on the
decomposition of substrate hydrogen peroxide, as indicated
by the decrease in absorbance at 240 nm [28]. GPx activity
was measured by the coupled method of Paglia and Valen-
tine using t-butyl hydroperoxide as a substrate [29]. The
results for SOD and GPx were expressed as U/gHb, and
for CAT as k/gHb, where k is the rate constant for the CAT
activity.
Determination of the CIMT
Ultrasonographic scanning of the carotid artery was per-
formed using a high-resolution ultrasonographer (Toshiba
Corevision high-resolution B-mode ultrasonography) pro-
vided with a 7.5 MHz linear transducer. All the measure-
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Table 1. Clinical and demographic characteristics of controls and patients
Control Uraemic group Haemodialysis group P
Number of patients 20 20 20
Male/female 10/10 10/10 11/9 0.94
Age (years) 56.7 ± 10.2 58.4 ± 10.1 55.4 ± 10.5 0.61
BMI (kg/m2) 25.98 ± 3.18 25.06 ± 4.52 24.83 ± 4.23 0.41
Smoking 0 11/9 12/8 0.75
Systolic blood pressure (mmHg) 129.29 ± 14.49 142.40 ± 12.50∗ 132.04 ± 20.41 0.05
Diastolic blood pressure (mmHg) 74.68 ± 9.77 86.09 ± 7.56∗ 75.45 ± 8.42† 0.001
Serum albumin (g/dl) 4.27 ± 0.18 4.66 ± 1.30 4.66 ± 0.78 0.12
PTH (pg/ml) — 70.40 ± 64.32 282.58 ± 229.75† 0.01
Glucose (mg/dl) 84.59 ± 10.97 95.15 ± 10.20 91.39 ± 17.14 0.07
HDL (mg/dl) 51.33 ± 17.61 44.27 ± 11.37 37.10 ± 12.49∗ 0.01
LDL (mg/dl) 122.94 ± 25.99 114.39 ± 34.75 103.75 ± 27.41 0.13
BMI: body mass index, PTH: parathormone.
Post hoc comparisons: ∗P < 0.05 versus control group; †P < 0.05 versus uraemic group.
Table 2. Oxidative stress parameters of controls and patients
Control Uraemic group Haemodialysis group P
TBARS (nmol/ml) 1.20 ± 0.48 1.36 ± 0.60 1.49 ± 0.59∗ 0.05
Nitrite + nitrate (µmol/l) 138.34 ± 27.85 171.27 ± 72.05 212.98 ± 71.00∗∗∗† <0.001
Carbonyl (nmol/mg protein) 0.55 ± 0.11 0.87 ± 0.14∗∗∗ 0.94 ± 0.13∗∗∗ <0.001
P-SH (µmol/l) 28.83 ± 5.48 23.53 ± 4.37∗∗∗ 19.71 ± 6.46∗∗∗†† <0.001
GSH (mg/gHb) 1.74 ± 0.33 1.93 ± 0.33∗ 2.29 ± 0.61∗∗† 0.006
Vitamin E (µmol/l) 60.29 ± 10.47 72.28 ± 9.77∗∗∗ 50.35 ± 13.47∗††† <0.001
SOD (U/gHb) 1646.24 ± 151.98 1429.27 ± 334.77∗∗∗ 1001.08 ± 386.76∗∗∗††† <0.001
CAT (k/gHb) 541.37 ± 145.35 248.67 ± 66.40∗∗∗ 207.85 ± 77.17∗∗∗†† <0.001
GPx (U/gHb) 2.33 ± 0.90 2.26 ± 0.58 1.59 ± 0.41∗∗∗†† 0.001
CIMT (mm) 0.52 ± 0.08 0.67 ± 0.10∗∗∗ 0.75 ± 0.14∗∗∗† <0.001
TBARS: serum thiobarbituric acid reactive substances, P-SH: plasma sulfhydryl, GSH: erythrocyte glutathione, SOD: superoxide dismutase, CAT:
catalase, GPx: glutathione peroxidase, CIMT: carotid artery intima-media thickness.
Post hoc comparisons: ∗P < 0.05 versus control group; ∗∗P < 0.01 versus control group; ∗∗∗P < 0.001 versus control group; †P < 0.05 versus uraemic
group; ††P < 0.001 versus uraemic group and †††P < 0.001 versus uraemic group.
Each subject was examined in the supine position in
a semi-dark room. The carotid artery was investigated
bilaterally and scanned at the level of the bifurcation of
the common carotid arteries. The image was focused on the
far wall of the artery. CIMT was taken as the distance from
the leading edge of the first echogenic line to the leading
edge of the second echogenic line. IMT was measured on
the longitudinal views of the far wall of the bilateral distal
common carotid arteries (1–3 cm proximal to the carotid
bifurcation) at the diastolic phase. CIMT was expressed as
the mean of six measurements (three on each side) [30]. No
measurement was made on the sites where a plaque existed.
Statistical analysis
All statistical tests were performed with a commercially
available statistical analysis program (SPSS 11.0 for Win-
dows). Continuous variables were expressed as mean ±
standard deviation while categorical variables were ex-
pressed in ratio. The Kruskal–Wallis and Mann–Whitney
U tests were used to compare oxidative stress markers and
CIMT measurements among the groups. Spearman’s corre-
lation test was performed to explore the correlation between
oxidative stress markers and CIMT. A multiple linear re-
gression model with oxidative stress markers, age, gender,
systolic and diastolic blood pressure and lipid profiles cor-
relating with CIMT was performed. P-values <0.05 were
interpreted as statistically significant.
Results
Clinical and demographic characteristics of the patients
and controls are given in Table 1. There were no significant
differences in age, BMI and gender among the groups.
Oxidative stress and antioxidant parameters measured
are shown in Table 2. The nitrite and nitrate levels were sig-
nificantly higher in the HD group compared to the uraemic
group and healthy controls (P < 0.001). The HD group had
significantly higher TBARS levels compared to controls
(P = 0.05). Plasma PCO content was significantly higher
in both the HD and uraemic groups compared to controls
(P < 0.001).
The HD group had significantly lower P-SH concentra-
tion than the uraemic group, while the difference in P-SH
concentration between the uraemic group and controls was
also significant (P < 0.001). The HD group had signif-
icantly higher GSH levels compared to controls and the
uraemic group, while the uraemic group had significantly
higher GSH levels than controls (P = 0.006). The uraemic
group had significantly higher serum vitamin E levels com-
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0.001). Both HD and uraemic patients had significantly
lower erythrocyte SOD levels compared to controls, while
the HD group had even lower erythrocyte SOD levels than
the uraemic group (P < 0.001). Both the HD and uraemic
groups had significantly lower CAT levels compared to
controls, while the lowest CAT levels were found in the
HD group (P < 0.001). The erythrocyte GPx level in HD
patients was significantly lower than the levels in uraemic
patients and control subjects (P = 0.001).
HD patients had significantly higher CIMT than uraemic
patients and healthy subjects, while the uraemic group had
also significantly higher CIMT values than control subjects
(P < 0.001).
There was a positive correlation between CIMT levels
and TBARS levels (r = 0.38, P = 0.003, Figure 1A). Sim-
ilarly, a positive correlation was found between CIMT and
nitrite and nitrate values (r = 0.41, P = 0.001, Figure 1B).
In contrast, there was a negative correlation between CIMT
and antioxidants; SOD (r = −0.35, P = 0.01, Figure 2A);
CAT (r = −0.65, P < 0.001, Figure 2B) and P-SH values
(r = −0.50, P < 0.001, Figure 2C). No significant correla-
tion was found between CIMT and other measured oxida-
tive stress and antioxidant parameters. However, there was
a significant correlation between CIMT and systolic blood
pressure (r = 0.42, P = 0.002).
We modelled a multiple linear regression analysis to de-
fine the independent determinants of CIMT. CIMT was
taken as a dependent variable. Age, gender, systolic and
diastolic blood pressure, creatinine, HDL cholesterol and
LDL cholesterol were incorporated into the model as inde-
pendent variables, in addition to TBARS, nitrite and nitrate
values, SOD, CAT and P-SH levels. The adjusted R2 of
the model was 0.725 with P <0.001. The linear regres-
sion model revealed that TBARS were still significantly
and positively correlated with CIMT (standardized beta =
0.349, P = 0.001) while CAT and P-SH were significantly
and negatively correlated with CIMT (standardized beta
= −0.384, P = 0.002 and standardized beta = −0.184,
P = 0.048, respectively) (Table 3).
Discussion
In our study, we assessed the relationship between the spe-
cific markers of oxidative stress, antioxidants and the pres-
ence of early sub-clinical atherosclerosis in humans deter-
mined by CIMT. We found a significant increase in CIMT
in the uraemic and HD groups compared to healthy con-
trols. The HD group had the highest CIMT values indicat-
ing a higher risk for atherosclerotic diseases. Our results
are in accordance with the previous studies that evaluated
atherosclerosis in HD patients using carotid ultrasonogra-
phy [3,19,31,32].
Our first novel contribution from this study was the
demonstration of a positive correlation between CIMT
and two oxidative stress markers: serum TBARS and ni-
trite/nitrate levels. The second novel finding of this study
was the negative correlation between CIMT and three
antioxidants: erythrocyte SOD, CAT and P-SH levels. We
suggest the use of TBARS and nitrite/nitrate levels as pos-
itive determinants and erythrocyte SOD, CAT and P-SH
Fig. 1. (A) Correlation between CIMT and serum TBARS levels.
(B) Correlation between CIMT and serum nitrite and nitrate levels.
levels as negative determinants of atherosclerosis. To the
best of our knowledge, no previous report for correlations
between CIMT and oxidative stress markers and antioxi-
dants in chronic renal disease patients exists in the literature.
We demonstrated that serum TBARS, erythrocyte SOD and
P-SH were still significantly correlated with CIMT when
adjusted by certain other factors affecting CIMT.
In our study, higher TBARS, PCO and nitrite/nitrate
levels indicate increased production of ROS and RNS, in
both HD and uraemic groups compared to healthy controls.
Our results are in accordance with the following data in
the current literature. A high prevalence of increased ox-
idative stress was reported to be associated with increased
risk of CV morbidity and mortality in adult HD patients
[9,33–37]. We found increased oxidative stress and CIMT
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Fig. 2. (A) Correlation between CIMT and erythrocyte SOD levels.
(B) Correlation between CIMT and erythrocyte CAT levels.
(C) Correlation between CIMT and P-SH levels.
Table 3. Linear regression analysis for defining the independent determi-
nants of CIMT
Independent variables β (coefficient) t-test value P
TBARS 0.349 3.693 0.001
CAT −0.384 −3.578 0.002
P-SH −0.184 −1.675 0.048
Age 0.237 2.406 0.021
R2 = 0.725, P < 0.001.
Out of the model: gender (P = 0.16); systolic and diastolic blood pres-
sure (P = 0.18 and P = 0.81, respectively); creatinine (P = 0.13); HDL
cholesterol (P = 0.23) and LDL cholesterol (P = 0.07); nitrite/nitrate
(P = 0.07) and SOD (P = 0.29).
role of oxidative stress in the development of accelerated
atherosclerosis in these patients.
There might be various mechanisms contributing to high
oxidative stress in chronic renal diseases. Increased ROS
and RNS generation and decreased antioxidant defences
have been implicated in the pathogenesis of oxidative
stress in uraemia [9,33–35]. Chronic inflammation, as evi-
denced by increased levels of pro-inflammatory cytokines,
is a common feature in HD patients. Activation of poly-
morphonuclear neutrophils and monocytes has been de-
scribed during HD, which results in the release of ROS and
cytokines [38]. Activated neutrophils generate superoxide
anions (O2−) that, combining with endothelial-derived NO,
form the highly cytotoxic hydroxyl radical [39]. Accumu-
lation of tumour necrosis factor-α and interleukin-1β in
supranormal amounts in uraemic plasma, being released
by monocytes activated on dialysis membrane, potently in-
duces NO synthesis [40–43].
Uraemia is associated with excessive systemic NO re-
lease, both in experimental model and in human beings. In
the systemic circulation of uraemic rats, as well as uraemic
patients, NO is formed in excessive amounts [12]. Data are
available in humans showing that platelets from uraemic
patients on HD generate more NO than healthy subjects
[40,41]. Plasma L-arginine was higher in uraemic patients
than in controls, and intraplatelet levels of cGMP (second
messenger of NO) were also higher in uraemic than in con-
trol platelets [40]. In addition, uraemic patients have higher
levels of NO in the exhaled air and higher plasma levels of
NO metabolites than normal humans [44–47]. It was also
demonstrated that uraemic plasma, unlike normal plasma,
was a potent inducer of NO in umbilical or microvascu-
lar endothelial cells [40,41]. Another possible cause of the
increased NO levels is higher release from systemic ves-
sels due to the augmented expression of both iNOS and
endothelial NOS. A putative cause for excessive NO pro-
duction in uraemia can be guanidinosuccinate, a uraemic
toxin that accumulates in the circulation of uraemic patients
and upregulates NO synthesis. Heparin, which is used as an-
ticoagulant during HD, might contribute to increased NO
production in HD patients, as indicated by its capability
to promote NO production by cultured human endothelial
cells [40,48].
We found a decrease in SOD, CAT, GPx and P-SH levels
in both HD and uraemic patients compared to the healthy
controls. Our data indicate that HD and predialytic uraemic
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be attributed in part to their antioxidant enzyme deficiency.
Our data led us to conclude that oxidative stress and dis-
turbances in antioxidant enzymes occur at the early stages
of chronic uraemia and are exacerbated by HD, which may
lead to the development of atherosclerosis and other long-
term complications in ESRD patients.
Limitations of the study
The major limitation of the study was definitely the small
sample size. The study was a cross-sectional study; a
prospective study following the uraemic patients until they
require and undergo HD treatment might yield better results
in exploring the effects of HD on the oxidative stress pa-
rameters in renal failure patients. However, our study is the
first to demonstrate a positive correlation between CIMT
and serum TBARS, and nitrite/nitrate levels and a negative
correlation between CIMT and erythrocyte SOD, CAT and
P-SH levels.
Conclusion
There is increased oxidative stress in HD and predialytic
uraemic patients compared to healthy subjects, with in-
creased risk for development of atherosclerotic diseases as
indicated by the presence of higher CIMT in these patients.
There was a significant positive correlation between CIMT,
and serum TBARS and nitrite/nitrate levels and a signifi-
cant negative correlation between CIMT, and SOD, CAT
and P-SH levels. We propose, for the first time in ESRD
patients, that serum TBARS and nitrite/nitrate levels can be
used as positive determinants while erythrocyte SOD, CAT
and P-SH levels may be used as negative determinants of
atherosclerosis assessed by CIMT.
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